Medication Adherence and Utilization in Patients With Schizophrenia or Bipolar Disorder Receiving Aripiprazole, Quetiapine, or Ziprasidone at Hospital Discharge: A Retrospective Cohort Study

BMC Psychiatry - United Kingdom
doi 10.1186/1471-244x-12-99
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Asenapine Treatment in Pediatric Patients With Bipolar I Disorder or Schizophrenia: A Review

Paediatric Drugs
Child HealthPediatricsPerinatologyPharmacology
2017English

Working Memory in Patients With Schizophrenia and Bipolar Affective Disorder: Quantitative or Qualitative Differences?

Psychiatria Danubina
MedicinePsychiatryMental Health
2019English

Psycho-Demographic and Clinical Predictors of Medication Adherence in Patients With Bipolar I Disorder in a University Hospital in Egypt

South African Journal of Psychiatry
PsychiatryMental Health
2020English

Mortality Rate Trends in Patients Diagnosed With Schizophrenia or Bipolar Disorder: A Nationwide Study With 20 Years of Follow-Up

International Journal of Bipolar Disorders
PsychiatryMental HealthBiological Psychiatry
2019English

Medication Continuity Among Medicaid Beneficiaries With Schizophrenia and Bipolar Disorder

Psychiatric Services
MedicinePsychiatryMental Health
2013English

Relationship of Insight With Medication Adherence and the Impact on Outcomes in Patients With Schizophrenia and Bipolar Disorder: Results From a 1-Year European Outpatient Observational Study

BMC Psychiatry
PsychiatryMental Health
2015English

Impact of Mood Disorder on Medication Adherence in Patients With Chronic Diseases at a Shanghai Rural Hospital

International Journal of Pharmacology
Pharmacology
2015English

Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127)

American Journal of Psychiatry
PsychiatryMental Health
2009English

Prospective Trial of Customized Adherence Enhancement Plus Long-Acting Injectable Antipsychotic Medication in Homeless or Recently Homeless Individuals With Schizophrenia or Schizoaffective Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy